8.50
0.00
(0.00%)
As of January 14 at 2:49:53 PM GMT. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
13,648.00
13,648.00
12,884.00
7,231.00
1,361.00
Cost of Revenue
2,948.00
2,948.00
4,754.00
2,751.00
636.00
Gross Profit
10,700.00
10,700.00
8,130.00
4,480.00
725.00
Operating Expense
14,902.00
14,902.00
17,752.00
13,608.00
7,383.00
Operating Income
-4,202.00
-4,202.00
-9,622.00
-9,128.00
-6,658.00
Net Non Operating Interest Income Expense
-5.00
-5.00
-6.00
-29.00
-2.00
Pretax Income
-4,207.00
-4,207.00
-17,386.00
-9,158.00
-8,117.00
Tax Provision
-962.00
-962.00
-798.00
-1,082.00
-503.00
Net Income Common Stockholders
-3,257.00
-3,257.00
-17,383.00
-8,432.00
-7,614.00
Diluted NI Available to Com Stockholders
-3,257.00
-3,257.00
-17,383.00
-8,432.00
-7,614.00
Basic EPS
-0.16
-0.04
-0.19
-0.10
-0.19
Diluted EPS
-0.16
-0.04
-0.19
-0.10
-0.19
Basic Average Shares
92,457.50
92,781.69
92,050.73
82,461.69
39,701.98
Diluted Average Shares
92,457.50
92,781.69
92,370.37
82,461.69
39,701.98
Total Operating Income as Reported
-4,202.00
-4,202.00
-17,380.00
-9,129.00
-8,024.00
Total Expenses
17,850.00
17,850.00
22,506.00
16,359.00
8,019.00
Net Income from Continuing & Discontinued Operation
-3,257.00
-3,257.00
-17,383.00
-8,432.00
-7,614.00
Normalized Income
-3,245.00
-3,245.00
-1,428.08
-8,076.00
-4,881.29
Interest Income
6.00
6.00
1.00
1.00
3.00
Interest Expense
11.00
11.00
7.00
30.00
5.00
Net Interest Income
-5.00
-5.00
-6.00
-29.00
-2.00
EBIT
-4,196.00
-4,196.00
-17,379.00
-9,128.00
-8,112.00
EBITDA
-165.00
-165.00
-12,544.00
-5,315.00
-6,765.00
Reconciled Cost of Revenue
2,948.00
2,948.00
4,754.00
2,751.00
636.00
Reconciled Depreciation
4,031.00
4,031.00
4,835.00
3,813.00
1,347.00
Net Income from Continuing Operation Net Minority Interest
-3,245.00
-3,245.00
-16,588.00
-8,076.00
-7,614.00
Total Unusual Items Excluding Goodwill
--
--
-7,758.00
--
-1,457.00
Total Unusual Items
--
--
--
--
-91.00
Normalized EBITDA
-165.00
-165.00
-12,544.00
-5,315.00
-6,674.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
-356.08
--
-90.29
3/31/2021 - 5/22/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3902.T Medical Data Vision Co., Ltd.
435.00
+1.64%
KOO.L Kooth plc
176.00
-2.49%
SHLT SHL Telemedicine Ltd.
2.8000
-3.45%
COP.DE CompuGroup Medical SE & Co. KGaA
21.82
+0.37%
EUDA EUDA Health Holdings Limited
3.5600
-13.38%
VASO Vaso Corporation
0.1100
0.00%
2228.HK XtalPi Holdings Limited
4.460
-1.55%
TRLS.L Trellus Health plc
3.7000
-25.25%
ADK.V DIAGNOS Inc.
0.3400
-1.45%
MGRX Mangoceuticals, Inc.
2.5800
-0.77%